JL

Jason Levin

Founder, Director and Chief Executive Officer

Orbus Therapeutics

Therapeutic Areas

Orbus Therapeutics Pipeline

DrugIndicationPhase
EflornithineAnaplastic Astrocytoma (AA3 / Grade 3 Glioma)Phase 3